TABLE 2.

Ages and genders of subjects completing the study

	PLACEBO SUBJECTS			RAPA SUBJECTS
	Subject	Age	Sex	Subject	Age	Sex	RAPA levelb
STUDY 1	001	≥90a	M	002	≥90	M	8.2 ng/ml
	003	≥90	M	004	88	M	6.1 ng/ml
	006	80	M	005	89	M	6.7 ng/ml
	007	89	M	009	≥90	M	7.4 ng/ml
STUDY 2	010	79	M	011	70	M	4.7 ng/ml
	013	86	M	015	77	M	6.8 ng/ml
	014	83	M	016	81	M	11.8 ng/ml
	018	≥90	M	021	75	M	6.1 ng/ml
	023	74	F	024	81	F	8.8 ng/ml
	027	71	F	030	70	F	7.8 ng/ml
	028	70	F	033	70	M	4.8 ng/ml
	029	73	F
	032	75	M
	034	75	F
Mean age with standard deviation		80.6 +/− 7.9 yrs			80.4 +/− 8.6 yrs

^a. Age over 89 yrs is considered an “identifier” by our IRB, so subjects 90 or above are indicated “≥90”

^b. The highest RAPA level in the blood attained during the course of the study is indicated for each subject in that treatment group.